In patients with lung adenocarcinoma, angiogenesis-altering drugs can alter the appearance of leptomeningeal metastasis on magnetic resonance imaging (MRI) scans. In the ventral brainstem, this can manifest as a unique, linear, non-enhancing T2-hyperintense signal.
Keywords: adenocarcinoma; brain; lung; magnetic resonance imaging; metastasis; tyrosine kinase inhibitors.
© 2024 The Author(s). Clinical Case Reports published by John Wiley & Sons Ltd.